JP2009526795A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526795A5
JP2009526795A5 JP2008554655A JP2008554655A JP2009526795A5 JP 2009526795 A5 JP2009526795 A5 JP 2009526795A5 JP 2008554655 A JP2008554655 A JP 2008554655A JP 2008554655 A JP2008554655 A JP 2008554655A JP 2009526795 A5 JP2009526795 A5 JP 2009526795A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
group
independently
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/001214 external-priority patent/WO2007093366A1/en
Publication of JP2009526795A publication Critical patent/JP2009526795A/ja
Publication of JP2009526795A5 publication Critical patent/JP2009526795A5/ja
Pending legal-status Critical Current

Links

JP2008554655A 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールジヒドロイソキノリノン、それらの製造方法及び薬剤としてそれらの使用 Pending JP2009526795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007048 2006-02-15
PCT/EP2007/001214 WO2007093366A1 (en) 2006-02-15 2007-02-13 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

Publications (2)

Publication Number Publication Date
JP2009526795A JP2009526795A (ja) 2009-07-23
JP2009526795A5 true JP2009526795A5 (enExample) 2010-04-02

Family

ID=38169583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554655A Pending JP2009526795A (ja) 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールジヒドロイソキノリノン、それらの製造方法及び薬剤としてそれらの使用

Country Status (16)

Country Link
US (1) US8501771B2 (enExample)
EP (1) EP1987006B1 (enExample)
JP (1) JP2009526795A (enExample)
KR (1) KR20080094699A (enExample)
CN (1) CN101384555A (enExample)
AR (1) AR059522A1 (enExample)
AT (1) ATE495157T1 (enExample)
AU (1) AU2007214711A1 (enExample)
BR (1) BRPI0707836A2 (enExample)
CA (1) CA2636617A1 (enExample)
DE (1) DE602007011897D1 (enExample)
IL (1) IL193339A0 (enExample)
MY (1) MY149854A (enExample)
TW (1) TW200800907A (enExample)
UY (1) UY30165A1 (enExample)
WO (1) WO2007093366A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
NZ573735A (en) * 2006-05-19 2011-10-28 Abbott Lab Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
CA2652385A1 (en) * 2006-06-08 2007-12-21 Eli Lilly And Company Novel mch receptor antagonists
US9623021B2 (en) * 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
KR101638035B1 (ko) 2007-01-22 2016-07-11 지티엑스, 인코포레이티드 핵 수용체에 결합하는 물질
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
CN102245600A (zh) * 2008-10-08 2011-11-16 百时美施贵宝公司 吡咯烷酮黑色素浓集激素受体-1拮抗剂
WO2011130086A1 (en) * 2010-04-12 2011-10-20 Merck Sharp & Dohme Corp. Pyridone derivatives
US8450350B2 (en) 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
CA2798330A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
TW201215387A (en) * 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
HRP20211778T1 (hr) 2014-08-29 2022-03-18 Chdi Foundation, Inc. Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina
WO2021028935A1 (en) * 2019-08-12 2021-02-18 Dr Reddy's Institute Of Life Sciences Heterocyclic compounds, and their use as allosteric modulators of 5-hydroxytryptamine 2c receptor (5-ht2cr)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10259176A (ja) * 1997-03-17 1998-09-29 Japan Tobacco Inc 血管新生阻害作用を有する新規アミド誘導体及びその用途
US7115750B1 (en) 1999-09-20 2006-10-03 Takeda Pharmaceutical Company Limited Melanin concentrating hormone antagonist
US6469026B2 (en) 2000-03-24 2002-10-22 Millennium Pharmaceuticals, Inc. Isoquinolone inhibitors of factor Xa
WO2002002744A2 (en) 2000-07-05 2002-01-10 Synaptic Pharmaceutical Corporation Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
EP1299362A4 (en) 2000-07-05 2004-11-03 Synaptic Pharma Corp SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
HUP0302966A2 (hu) 2000-07-31 2003-12-29 Smithkline Beecham P.L.C. Karboxamid-vegyületek és alkalmazásuk humán 11CBY receptor antagonistákként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US20030022891A1 (en) 2000-12-01 2003-01-30 Anandan Palani MCH antagonists and their use in the treatment of obesity
ES2319619T3 (es) 2001-05-04 2009-05-11 Amgen Inc. Compuestos heterociclicos condensados.
GB0124627D0 (en) 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
CZ2004634A3 (cs) 2001-10-25 2004-10-13 Takedaáchemicaláindustriesźáltd Chinolinová sloučeninaŹ způsob výroby a použití a farmaceutický přípravek
AU2002352878B2 (en) 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
US7229987B2 (en) 2002-05-13 2007-06-12 Eli Lilly And Company Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
DE10238865A1 (de) 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
US7390820B2 (en) 2003-08-25 2008-06-24 Amgen Inc. Substituted quinolinone derivatives and methods of use
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ グループ リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
WO2005047293A1 (en) 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0507629A (pt) * 2004-02-13 2007-07-03 Banyu Pharma Co Ltd composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
US20050256124A1 (en) 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto

Similar Documents

Publication Publication Date Title
JP2009526793A5 (enExample)
JP2009526792A5 (enExample)
RU2008136898A (ru) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств
JP2009526794A5 (enExample)
TWI712595B (zh) 三環性螺化合物
JP6259855B2 (ja) インフルエンザウイルス複製の阻害剤
ES2572803T3 (es) Estimuladores de GCs
CN102812006B (zh) 新型抗疟疾试剂
JP6557674B2 (ja) 新規クラスのミュー−オピオイド受容体アゴニスト
JP2021527638A (ja) B型肝炎カプシドアセンブリモジュレーター
ES2573715T3 (es) Ligandos sigma para la prevención y/o el tratamiento del vómito inducido por la quimioterapia o la radioterapia
JP2006501202A5 (enExample)
JP2006517563A5 (enExample)
CN101454299A (zh) 酰脲衍生物及其医药用途
DK3083592T3 (en) SUBSTITU
AU2009310807B2 (en) Cyclohexane derivative and pharmaceutical use thereof
ES2995040T3 (en) Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
AU2021200164A1 (en) Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US9624198B2 (en) Substituted piperidinyltetrahydroquinolines
TW201605433A (zh) NSAID與西克馬(sigma)受體配位體之組合
TW200904817A (en) Compounds and uses thereof
JP2008531679A (ja) オキシトシンアンタゴニストとしての1,2,4−トリアゾール誘導体とその使用
CA2934134A1 (en) Substituted bipiperidinyl derivatives as adrenoreceptor alpha 2c antagonists
ES2708577T3 (es) Composición medicinal que mejora la resistencia a la leptina
TW200911760A (en) Compounds and uses thereof